Trial intelligence / Profile preview

The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment

NCT04931095Phase 1Completed

Sponsor
Johns Hopkins University
Start
Feb 2022
Primary completion
Aug 2025
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of cannabis and ethanol (7 arms), sponsored by Johns Hopkins University. Primary endpoints: DRUID Application Global Impairment Score at 7.5 hours, Cumulative Score on Field Sobriety Tests at 7.5 hours and 9 more. Started Feb 2022; status: completed.

02

Drugs

cannabisethanol

Beyond the preview

Go deeper on NCT04931095.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04931095.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call